Quintiles Receives Third Technology Security Award from IDG’s CSO Magazine
2015年2月25日 - 10:00PM
ビジネスワイヤ(英語)
Quintiles’ Risk Mitigation Strategy Recognized
in CSO50
Quintiles announced today that it has been named to the 2015
CSO50 by IDG's CSO magazine in recognition of the company’s risk
mitigation strategy managing Windows XP security challenges.
CSO commended the Quintiles team for its innovative
defense-in-depth model which minimized security risks for
business-critical applications dependent on Windows XP, delivering
secure and segmented platforms while protecting critical company
assets.
“This was an innovative solution to a problem that presents
significant security concerns for many organizations around the
world,” said Quintiles Chief Information Security Officer Patricia
Collins Weedon. “Quintiles has launched many innovative customer
solutions that require our team to think beyond current cyber
security, compliance, and data protection challenges. We are
honored to receive this award in recognition for the sterling work
our world-class security team undertakes 24 x 7,” Weedon added.
Each year, the CSO50 Awards recognize 50 organizations for
security projects and initiatives that demonstrate outstanding
business value and thought leadership. Nominations are scored on a
uniform set of criteria by a panel of judges including security
leaders, industry experts, and academics. The final winning
selections are made by CSO's editors based on this scoring
process.
“For the third year in a row, outstanding organizations
demonstrating innovation, creativity and understanding of business
value in security were chosen from a large pool of submissions."
said Joan Goodchild, editor, CSO. "We congratulate this year's
CSO50 winners and applaud them for setting the bar high for
security's role in providing value and ROI in business."
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s
largest provider of biopharmaceutical development and commercial
outsourcing services. With a network of more than 32,000 employees
conducting business in approximately 100 countries, we helped
develop or commercialize all of 2013’s top-100 best-selling drugs
on the market. Quintiles applies the breadth and depth of our
service offerings along with extensive therapeutic, scientific and
analytics expertise to help our customers navigate an increasingly
complex healthcare environment as they seek to improve efficiency
and effectiveness in the delivery of better healthcare outcomes. To
learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
QuintilesPhil Bridges, Media Relations
(phil.bridges@quintiles.com)+ 1.919.998.1653 (office)
+1.919.457.6347 (mobile)orKarl Deonanan, Investor Relations
(InvestorRelations@quintiles.com)+1.919.998.2789
Qimonda AG Ads (NYSE:QI)
過去 株価チャート
から 7 2024 まで 8 2024
Qimonda AG Ads (NYSE:QI)
過去 株価チャート
から 8 2023 まで 8 2024